Trailhead Biosystems, a pioneering biotechnology company specializing in the development of iPSC-derived human cells for drug discovery and cell therapy, is pleased to announce the appointment of Dr.
Two anti-transferrin receptor (TfR) nanobodies, V H H123 specific for mouse TfR and V H H188 specific for human TfR (huTfR) were used to track transplants non-invasively by PET/CT in mouse models, ...